Your browser doesn't support javascript.
loading
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial.
Goldin, Mark; Giannis, Dimitrios; Diab, Wassim; Wang, Janice; Khanijo, Sameer; Sharifova, Gulru; Cohen, Marc; Lund, Jeet M; Mignatti, Andrea; Gianos, Eugenia; Tafur, Alfonso; Lewis, Paul A; Cohoon, Kevin; Kittelson, John M; Lesser, Martin L; Sison, Cristina P; Rahman, Husneara; Ochani, Kanta; Hiatt, William R; Dale, Rita A; Anderson, Victoria E; Bonaca, Marc; Halperin, Jonathan L; Weitz, Jeffrey I; Spyropoulos, Alex C.
Afiliação
  • Goldin M; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.
  • Giannis D; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.
  • Diab W; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.
  • Wang J; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.
  • Khanijo S; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.
  • Sharifova G; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.
  • Cohen M; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.
  • Lund JM; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.
  • Mignatti A; Department of Medicine, Newark Beth Israel Medical Center, Newark, New Jersey, United States.
  • Gianos E; Wellspan York Hospital, York, Pennsylvania, United States.
  • Tafur A; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.
  • Lewis PA; Department of Cardiology, Lenox Hill Hospital, Northwell Health, New York, New York, United States.
  • Cohoon K; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.
  • Kittelson JM; Department of Cardiology, Lenox Hill Hospital, Northwell Health, New York, New York, United States.
  • Lesser ML; Department of Medicine and Vascular Medicine, NorthShore University Health System, Evanston, Illinois, United States.
  • Sison CP; Division of Cardiology, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, United States.
  • Rahman H; Evidence Based Medicine, Baycare Health System, Clearwater, Florida, United States.
  • Ochani K; Division of Cardiovascular Medicine, Department of Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
  • Hiatt WR; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.
  • Dale RA; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.
  • Anderson VE; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.
  • Bonaca M; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.
  • Halperin JL; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.
  • Weitz JI; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.
  • Spyropoulos AC; Institute of Health Innovations and Outcomes Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.
Thromb Haemost ; 121(12): 1684-1695, 2021 12.
Article em En | MEDLINE | ID: mdl-33823560
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia / Enoxaparina / Tratamento Farmacológico da COVID-19 / Anticoagulantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Thromb Haemost Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia / Enoxaparina / Tratamento Farmacológico da COVID-19 / Anticoagulantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Thromb Haemost Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Alemanha